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Abstract
Background: orthostatic hypotension (OH) that occurs within, or at, 1 minute of standing is associated with higher risk of
falls, myocardial infarction, syncope and mortality, compared to OH that occurs after 1 minute of standing. Whether vitamin
D deficiency increases the risk of OH is controversial.
Methods: this was a cross-sectional analysis of 3,620 older, community-dwelling men. Multinomial, multiple logistic
regression models were used to calculate the risk of OH across categories of vitamin D status (deficient [<25 nmol/l],
insufficient [≥25–<50 nmol/l] and sufficient [≥50 nmol/l]) and parathyroid hormone quintile.
Results:men with vitamin D deficiency were more likely to have OH that occurred within 1 minute of standing in univariate
logistic regression (OR 1.88, 95%CI 1.40–2.53) andmultinomial, multiple logistic regression (OR 1.51, 95%CI 1.06–2.15),
compared to men with sufficient levels of vitamin D. Vitamin D insufficiency was not associated with the risk of OH. Elevated
parathyroid hormone was not associated with risk of OH.
Conclusion: the absence of an association between vitamin D insufficiency and risk of OH and the presence of an association
between vitamin D deficiency and risk of OH suggest that there may be a threshold effect; it is only below a particular level
of vitamin D that risk of OH is increased. In this cohort, the threshold was <25 nmol/l. Future work should investigate
whether treating vitamin D deficiency can improve postural blood pressure or if preventing vitamin D deficiency reduces the
incidence of OH.
Keywords: geriatrics, epidemiology, orthostatic hypotension, vitamin D, older people
Key points
• Men with vitamin D deficiency had increased risk of OH that occurred within 1 minute of standing.
• Vitamin D insufficiency and elevated PTH were not statistically significantly associated with risk of OH.
• The controversy in this area of research may be explained, in part, by different definitions of vitamin D deficiency.
• Thresholds to define vitamin D deficiency may need to be disease or adverse outcome-specific.
• Interventional studies may clarify whether vitamin D supplementation can improve OH.
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Introduction
Whether vitamin D deficiency increases risk of orthostatic
hypotension (OH) is controversial [1–7]. Almost 1 in 3
adults >65 years old is deficient in vitamin D during the
winter months in the United Kingdom [8], while OH is
found in over 1 in 5 community-dwelling older adults [9].
OH increases the risk of falls, fractures, cardiovascular disease
and all-cause mortality [10–12]. It is also associated with
late-life depression and dementia [13,14]. OH that occurs
within, or at, 1 minute of standing has been associated
with higher risk of falls, myocardial infarction (MI), syn-
cope and mortality, compared to OH that occurs after 1
minute of standing [15–17]. It is important to clarify the
association between vitamin D deficiency and OH because
current treatment options for OH are limited, and vitamin
D supplements are cheaply and widely available.
Smaller studies suggest that lower levels of circulating
vitamin D are associated with increased risk of OH
[1–3,5,7], while larger studies do not [6,18], and the current
evidence base has specific limitations. Firstly, not all of the
studies controlled for parathyroid hormone (PTH). PTH
and vitamin D work in concert, through feedback cycles
[19], so PTH may mediate, or confound, the association
between vitamin D and OH. Secondly, men have been
underrepresented in the current evidence base: only 27% of
those with low circulating vitamin D in a systematic review
and meta-analysis investigating the association between
circulating vitamin D and OH were men [4]. Thirdly, few
studies have examined whether vitamin D status relates to
the timeframe within which OH occurs [6,18]. Finally,
none of the available studies have investigated a UK-based
cohort. This is relevant because circulating vitamin D
concentration is determined by dietary sources and synthesis
in the skin via exposure to ultraviolet radiation [20],
factors that are geographically dependent [21]. Therefore,
the external validity of the currently available data is
limited.
In this cross-sectional study, we aimed to address these
issues by exploring the association between circulating
vitamin D, PTH and OH in older, community-dwelling,
men.
Methods
Study population
This analysis was based on data from the 20th year rescreen
of participants of the British Regional Heart Study. Sampling
methods have been described previously [22]. The British
Regional Heart Study is an on-going prospective cohort
study that first recruited 7,735 men, aged 40–59 years,
between 1978 and 1980, from one general practice in each of
24 British towns. The sample was socioeconomically repre-
sentative of the population. Participants were predominantly
(>99%) of white European ethnicity. For the 20th year
rescreen, all surviving men were invited for reexamination
that took place between 1998 and 2000. A total of 4,252
men completed a self-administered questionnaire and under-
went physical examination (77% response rate) [22, 23].
Ethical approval was obtained from the National Research
Ethics Service Committee London.
A total of 3,799 men had a vitamin D measurement,
and 109 men with prevalent heart failure were excluded
because heart failure is strongly associated with hypertension
[24], a major determinant of OH [25–28], and because
of their exceptionally high risk of mortality [29]. A total
of 67 participants with incomplete sitting and standing
blood pressure (BP) measurements were also excluded.
We further excluded two men with PTH measurements
>200 pg/ml, as these measurements likely reflected a specific
disease such as hyperparathyroidism, and one man with
a circulating vitamin D level >250 nmol/l. Thus, 3,620
participants were left for analysis. Of these, 3,618 had PTH
measurements.
Vitamin D and PTH measurements
A fasting blood sample was taken on the same day as
the physical examination. Total vitamin D (25OHD2
plus 25OHD3; referred to here as ‘vitamin D’) was
measured using a gold-standard liquid chromatography–
tandem mass spectrometry method following an automated
solid-phase extraction procedure [30]. Measurements were
made in ng/ml and converted into nmol/l. The lower
limit of sensitivity was 10 nmol/l. PTH was measured by
electrochemiluminescence using a clinically validated assay
for intact PTH [30].
BP measurement
BP measurements were taken on the right arm using an
automatic Dinamap 1846SX. The Dinamap BP monitor
overestimated systolic BP by ∼8 mmHg compared with the
standard mercury sphygmomanometer that was the standard
reference instrument for BP measurement at the time [31].
8 mmHg was therefore subtracted from raw systolic BP
readings. Cuff size was selected in accordance with arm
circumference: a standard adult cuff if the arm circumference
was between 28.0 cm and 35.0 cm, a small adult cuff if it
was <28.0 cm and a large adult cuff if it was >35.0 cm.
For sitting measurements, participants were asked to rest
their arm on the examination table, such that the upper arm
was at chest level. During measurements, participants were
discouraged from talking and encouraged to keep the arm
still.
The Dinamap was set to take repeated measurements at 1
minute intervals. Four consecutive BP measurements were
taken: two sitting, followed by two standing. Participants
had not been seated, nor supine, for a prescribed duration
prior to the first sittingmeasurement. After the second sitting
measurement completed, the participant was asked to stand
up (at least 1 minute and 30 seconds after sitting down for
2
D
ow
nloaded from
 https://academ
ic.oup.com
/ageing/advance-article/doi/10.1093/ageing/afaa146/5891701 by guest on 25 Septem
ber 2020
Vitamin D deficiency is associated with orthostatic hypotension in older men
the first BP measurement). The first standing BP measure-
ment began within 1 minute of the participant standing.The
second standing BP measurement began after 1 minute of
standing.
Definition of OH
‘Consensus OH’ was defined by consensus [32] as a decrease
in systolic BP ≥20 mmHg and/or diastolic BP ≥10 mmHg
that occurred between either the first, or second, stand-
ing BP measurements and the mean of the two preceding
sitting BP measurements. Consensus OH was subdivided,
based on the timeframe within which it occurred, into
OH-1 and OH-2. OH-1 was OH that occurred within
1 minute of standing, regardless of whether it persisted
or corrected during the second minute of standing; OH-2
was OH that only occurred during the second minute of
standing.
Statistical methods
Statistical analyses were performed using SAS 9.4. Vita-
min D status was categorized as per the United Kingdom’s
National Institute for Health and Care Excellence Clin-
ical Knowledge Summaries [33]: deficient (<25 nmol/l),
insufficient (≥25–<50 nmol/l) or sufficient (≥50 nmol/l).
The ‘sufficient’ group was the reference group for hypoth-
esis testing. In the case of PTH, participants were divided
into quintiles. The first (lowest) quintile was the reference
group. Comparisons of baseline characteristics were per-
formed using the chi-square test for categorical variables and
generalized linear models for continuous variables.
Loess regression was used to plot the curves for the associ-
ation between probability of OH and circulating vitamin D
and PTH. Logistic regression was used to assess the associa-
tion between vitamin D status and OH, and PTH quintile
and OH. Multinomial logistic regression was used to exam-
ine the association between vitamin D status and timeframe
of OH (OH-1 and OH-2). The reference group (‘No OH’)
consisted of participants who had neither OH-1 nor OH-2.
Age, body mass index (BMI), resting pulse, systolic BP, total
cholesterol, PTH and IL-6 were fitted as continuous vari-
ables in the multiple regression models. Categorical covari-
ates were smoking status (never smoked, ex-smoker for 0–
15 years, ex-smoker for>15 years and current smoker), alco-
hol use (0–15 units/week and >16 units/week), season in
which blood samples for vitamin Dmeasurement were taken
(spring, summer, autumn or winter), physical activity (active
or inactive), physical disability (no disability, mild disability
or moderate disability), self-reported vitaminD ormultivita-
min supplementation (taking supplementation or not taking
supplementation), social class (manual or nonmanual) and
the presence of prevalent stroke, MI, atrial fibrillation (AF),
diabetes, chronic kidney disease (CKD), chronic obstructive
pulmonary disease (COPD) and current antihypertensive
medication use.
Case definitions of MI, stroke and diabetes were obtained
from primary care record reviews [34]. AF was defined
according toMinnesota codes 8.3.1 and 8.3.3. Hypertension
was defined as mean sitting systolic BP≥140 mmHg and/or
mean sitting diastolic BP ≥90 mmHg and/or antihyperten-
sive medication use. Antihypertensive medication use was
based on self-report and defined as use of any antihyperten-
sive medication as per British National Formulary (version
38) code 3.1. CKD was defined as an estimated glomerular
filtration rate <60 ml/minute/1.73 m2, as estimated from
serum creatinine using the Modification of Diet in Renal
Disease equation [35]. ‘Inactive’ was defined as inactivity or
occasional physical activity based on self-reported question-
naire data. Definitions of physical disability were based on
self-reported questionnaire responses to questions regarding
difficulty going up or down stairs and difficulty walking
for a quarter of a mile on the level. ‘No disability’ was
if participants did not have difficulty with either, ‘mild
disability’ if they reported difficulty with one or the other
and ‘moderate disability’ if they reported difficulty with both.
Methods of measurement and classification for measures
of lipids, lung function, smoking status, physical activity,
alcohol intake and social class have been described previously
[36, 37].
Results
Among 3,620 community-dwelling men (mean age
68.6 years, SD 5.5 years), 10% had vitamin D deficiency.
Men with vitamin D deficiency tended to have the most
adverse characteristics (Table 1). They were older, more
likely to be current smokers, inactive, disabled and had
the highest prevalence of stroke, diabetes, COPD and
antihypertensive medication use. They had the highest mean
levels of resting pulse, sitting systolic BP, CRP, IL-6 and
PTH.
There was a nonlinear association between probability of
consensus OH and circulating vitamin D level, suggestive of
a threshold effect occurring at a level below approximately
40 nmol/l, where probability of OH increased (Figure 1A).
Higher concentration of PTH correlated with increased
probability of consensus OH (Figure 1B).
Vitamin D status and risk of OH
Consensus OH was found in 26.5, 19.6 and 18.6% of
those with vitamin D deficiency, vitamin D insufficiency
and sufficient circulating vitamin D, respectively (Table 2).
Compared to men with sufficient circulating vitamin D,
only men with vitamin D deficiency had statistically signif-
icantly increased risk of consensus OH (OR 1.57, 95% CI
1.21–2.05). This association was markedly attenuated, and
not statistically significant, in multiple logistic regression
analysis (OR 1.31, 95% CI 0.96–1.78) (Table 2). When
consensus OH was divided into its components based on
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Table 1. Baseline characteristics of the study population stratified by vitamin D status (nmol/l)
Deficient: <25 (n = 363) Insufficient: ≥25–<50 (n = 1,533) Sufficient: ≥50 (n = 1724)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Anthropometric measurements Mean (SD) P
Age, years 69.3 (5.7) 68.7 (5.5) 68.4 (5.4) 0.0064
BMI, kg/m2 26.8 (4.5) 27.1 (3.8) 26.6 (3.3) 0.0003
Waist circumference, cm 98.3 (12.5) 97.8 (10.6) 96.0 (9.5) <0.0001
Sitting systolic BP, mmHg 152.6 (26.5) 148.7 (24.1) 149.1 (23.6) 0.0207
Sitting diastolic BP, mmHg 84.9 (12.1) 85.1 (11.3) 85.4 (10.8) 0.5148
Heart rate, beats per minute 68 (13) 66 (13) 65 (12) <0.0001
Arm circumference, cm 30.0 (3.4) 30.5 (2.9) 30.3 (2.6) 0.0266
Biochemical measurements Mean (SD)
CRPa, mg/l 2.3 (1.0–5.1) 1.7 (0.9–3.4) 1.6 (0.8–3.1) <0.0001
IL-6a, mg/l 3.0 (1.8–4.4) 2.5 (1.6–3.6) 2.2 (1.5–3.1) <0.0001
PTHa, pg/ml 53.5 (41.3–69.4) 46.5 (38.1–57.4) 42.1 (33.8–51.9) <0.0001
Cholesterol, mmol/l 5.8 (1.1) 6.0 (1.1) 6.0 (1.1) 0.0046
HDL, mmol/l 1.3 (0.4) 1.3 (0.4) 1.3 (0.3) 0.0909
Phosphate, mmol/l 1.2 (0.2) 1.2 (0.2) 1.2 (0.2) 0.8599
Calcium, mmol/l 2.3 (0.1) 2.3 (0.1) 2.4 (0.1) 0.0783
Vitamin D, nmol/l 16.9 (5.5) 37.0 (6.9) 69.0 (17.2) <0.0001
Co-morbid conditions (n, %)
Hypertension 284 (78.2) 1,142 (74.5) 1,285 (74.6) 0.3044
MI 31 (8.5) 94 (6.1) 104 (6.0) 0.1872
Stroke 20 (5.5) 47 (3.1) 38 (2.2) 0.0026
AF 18 (5.0) 53 (3.5) 49 (2.9) 0.1151
Diabetes 29 (8.0) 102 (6.7) 79 (4.6) 0.0071
CKD 50 (13.8) 219 (14.4) 247 (14.4) 0.9545
Antihypertensive use 131 (36.1) 476 (31.1) 509 (29.5) 0.0478
COPD 123 (35.1) 407 (26.7) 418 (24.4) 0.0002
Lifestyle, physical disability and social
class (n, %)
Current smokers 91 (25.1) 200 (13.1) 168 (9.8) <0.0001
Moderate to heavy alcohol
consumption
80 (22.7) 290 (19.2) 332 (19.5) 0.3253
Inactive 195 (56.9) 515 (34.8) 469 (28.1) <0.0001
Physical disability 55 (15.2) 131 (8.6) 133 (7.7) <0.0001
Manual social class 192 (53.2) 779 (50.9) 886 (51.5) 0.7220
Vitamin D/calcium supplementation and
season of examination (n, %)
Vitamin D supplements 10 (2.8) 66 (4.3) 169 (9.8) <0.0001
Calcium supplements 3 (0.8) 14 (0.9) 16 (0.9) 0.9830
Spring 114 (31.4) 410 (26.7) 266 (15.4) <0.0001
Summer 72 (19.8) 309 (20.2) 555 (32.2)
Autumn 59 (16.3) 389 (25.4) 624 (36.2)
Winter 118 (32.5) 425 (27.7) 279 (16.2)
aGeometric mean (interquartile range)
timeframe, in multinomial, multiple logistic regression anal-
ysis that included PTH and co-morbidities as covariates,
there was a statistically significant association between vita-
min D deficiency and OH-1 (OR 1.51, 95% CI 1.06–
2.15) but not OH-2. Vitamin D insufficiency was not
statistically significantly associated with OH-1 or OH-2
(Table 2).
PTH and risk of OH
After adjustment for age, BMI, resting pulse and mean
sitting systolic BP, there was no statistically significantly
increased risk of consensus OH, OH-1 or OH-2 in partici-
pants with elevated PTH levels (Table 3).
Discussion
In this cross-sectional study of older, community-dwelling
men, vitamin D deficiency was associated with increased
risk of OH that occurred within 1 minute of standing. No
association was seen between vitamin D insufficiency and
risk of OH or elevated PTH and risk of OH, regardless of
the timeframe within which OH occurred. The association
between vitamin D deficiency and OH was independent
of BP and PTH. The vitamin D receptor is found in car-
diomyocytes and vascular endothelial cells [38], vitamin
D deficiency may contribute to endothelial dysfunction
[39] and upregulation of the renin-angiotensin-aldosterone
system [40], and vitamin D itself may promote vascular
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Figure 1. Fit plots generated through loess regression for the
probability between OH and vitamin D (A) and OH and
PTH (B).
regeneration after injury [41]. Hence, theremay be a specula-
tive, but biologically plausible, mechanism that may underlie
the observed association.
Smaller studies have reported an association between
vitamin D status and OH [1–3,5,7], while larger studies
have not [6,18]. The inconsistencies may be explained
by different definitions of vitamin D deficiency, different
reference groups and different definitions of OH, with
respect to the timeframe within which OH occurs (Table 4).
Indeed, we detected a statistically significant association
between vitamin D deficiency and OH-1, but not OH-2.
Furthermore, when we reanalyzed our data with<30 nmol/l
as the cut-off to define vitamin D deficiency (data not
shown), there was no statistically significant association
between vitamin D deficiency and OH, irrespective of
timeframe. In one randomized controlled trial, vitamin D
supplementation did not result in a statistically significant
improvement in OH [42]. However, the sample size limited
the size of the reduction in OH that could have been
detected.
The definition of vitaminD deficiency remains controver-
sial [43]; the United Kingdom’s National Institute for Health
and Care Excellence Clinical Knowledge Summaries defines
it as <25 nmol/l [33], while the United States’ Institute
of Medicine defines it as <30 nmol/l [44]. The cut-offs
may need to be disease and/or adverse-outcome specific;
our findings suggest a cut-off of <25 nmol/l is associated
with risk of OH, while a cut-off of <30 nmol/l is not,
i.e. only those with extremely low circulating vitamin D
concentrations are at increased risk of OH.
Strengths of our study include the large sample size,
a gold standard measurement of vitamin D and that we
examined PTH, alongside a wide range of other possi-
ble confounders or mediators. Limitations include, firstly,
that men with OH were identified based on sitting and
standing BP measurements, rather than lying and standing
measurements. We used the thresholds that are ordinarily
used for lying and standing measurements to identify men
with OH, as the optimal thresholds to diagnose OH based
on sitting and standing measurements are not known. If
these thresholds are lower than those for lying and stand-
ing measurements, then we would have underestimated the
proportion of men with OH. Further factors that may have
reduced detection of OH include the men not being seated
for a prescribed duration prior to the first BP measurement
and using an automatic BP monitor to measure BP, rather
than taking continuous beat-to-beat BP measurements. Sec-
ondly, we did not have data on diagnosis of Parkinson’s
disease, a neurodegenerative condition in which OH is often
found, and are unable to exclude this as a confounding
factor. Thirdly, although we adjusted for antihypertensive
medications, we did not adjust for other drugs that may
causeOH, such as antipsychotics, antidepressants or opioids.
Fourthly, 424 men did not have a vitamin D measure-
ment and were excluded from the sample. However, there
was no statistically significant difference in age, physical
disability and in proportion of people with OH between
these men and those who had vitamin D measurements.
Therefore, their exclusion was unlikely to bias the findings.
Fifthly, although we controlled for physical disability, we
were unable to control specifically for frailty, which is asso-
ciated with both vitamin D [45] and OH [46], and there-
fore cannot exclude the possibility of residual confounding.
Sixthly, all of our participants were men, and the vast major-
ity (>99%) were of white European ethnicity; the general-
izability of our findings is restricted. Finally, this study was
cross-sectional; we are unable to comment on temporality
and causation.
In conclusion, vitaminD deficiency increased odds of OH
that occurred within 1 minute of standing in this cohort
of older men. Risk of OH increased only below a par-
ticular threshold of circulating vitamin D (<25 nmol/l).
Prospective studies specifically looking at threshold effects
and the significance of timeframe of OH are required
to assess whether vitamin D deficiency precedes OH.
Interventional studies may clarify whether vitamin D
supplementation could be an effective preventative measure
against OH, or whether it may be a treatment option for
those who have OH.
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Table 2. Odds of prevalent OH stratified by vitamin D status (nmol/l)
Model Deficient: <25 (n = 363) Insufficient: ≥25–<50 (n = 1,533) Sufficient: ≥50 (n = 1,724) P (trend). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
OH-C, n (%) 96 (26.45) 300 (19.57) 321 (18.62)
1 1.57 (1.21–2.05) 1.06 (0.89–1.27) 1.00 0.0049
2 1.48 (1.13–1.94) 1.03 (0.86–1.24) 1.00 0.0231
3 1.29 (0.95–1.75) 1.02 (0.84–1.23) 1.00 0.1977
4 1.31 (0.96–1.78) 1.00 (0.82–1.21) 1.00 0.2294
OH-1, n (%) 73 (20.11) 196 (12.79) 204 (11.83)
1 1.88 (1.40–2.53) 1.09 (0.89–1.35) 1.00 0.0005
2 1.8 (1.33–2.45) 1.08 (0.87–1.34) 1.00 0.0016
3 1.56 (1.10–2.20) 1.09 (0.87–1.38) 1.00 0.0278
4 1.51 (1.06–2.15) 1.05 (0.83–1.33) 1.00 0.0617
OH-2, n (%) 23 (6.34) 104 (6.78) 117 (6.79)
1 1.03 (0.65–1.65) 1.01 (0.77–1.33) 1.00 0.8893
2 0.94 (0.58–1.51) 0.95 (0.71–1.26) 1.00 0.6990
3 0.86 (0.52–1.43) 0.89 (0.66–1.20) 1.00 0.4228
4 0.94 (0.56–1.59) 0.91 (0.67–1.23) 1.00 0.6221
Model 1: unadjusted. Model 2: age- and season-adjusted. Model 3 =Model 2 plus BMI, heart rate, mean sitting systolic BP, total cholesterol, smoking, alcohol
consumption, physical activity, social class, vitamin D supplementation, prevalent stroke, MI, AF, diabetes, antihypertensive medication use, CKD and COPD.
Model 4 =Model 3 plus physical disability, PTH and IL-6. ‘OH-C’ is consensus OH; ‘OH-1’ is OH occurring within 1 minute of standing; ‘OH-2’ is OH occurring
after 1 minute of standing. The given P-value is the P for trend
Table 3. Odds of prevalent OH between quintiles of PTH level
PTH Quintile (pg/ml)
Model Q1: ≤34.2
(n = 727)
Q2: >34.2–≤41.2
(n = 723)
Q3: >41.2–≤48.8
(n = 721)
Q4: >48.8–≤59.2
(n = 721)
Q5: >59.2 (n = 726) P (trend)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
OH-C, n (%) 119 (16.37) 144 (19.92) 145 (20.11) 153 (21.22) 154 (21.21)
1 1.00 1.27 (0.97–1.66) 1.29 (0.98–1.68) 1.38 (1.06–1.8) 1.38 (1.06–1.79) 0.0188
2 1.00 1.25 (0.96–1.64) 1.27 (0.97–1.66) 1.33 (1.02–1.73) 1.3 (0.99–1.69) 0.0635
3 1.00 1.24 (0.94–1.64) 1.20 (0.91–1.59) 1.25 (0.95–1.65) 1.13 (0.86–1.49) 0.4655
OH-1, n (%) 80 (11) 90 (12.45) 93 (12.90) 94 (13.04) 115 (15.84)
1 1.00 1.18 (0.86–1.63) 1.23 (0.89–1.69) 1.26 (0.91–1.73) 1.53 (1.12–2.08) 0.0085
2 1.00 1.16 (0.84–1.60) 1.21 (0.88–1.67) 1.21 (0.88–1.66) 1.43 (1.05–1.95) 0.0311
3 1.00 1.15 (0.83–1.61) 1.14 (0.82–1.59) 1.14 (0.82–1.58) 1.25 (0.91–1.72) 0.2261
OH-2, n (%) 39 (5.36) 54 (7.47) 52 (7.21) 59 (8.18) 39 (5.37)
1 1.00 1.45 (0.95–2.23) 1.41 (0.92–2.16) 1.62 (1.06–2.47) 1.06 (0.67–1.68) 0.6030
2 1.00 1.44 (0.94–2.20) 1.39 (0.91–2.15) 1.58 (1.03–2.40) 1.02 (0.64–1.61) 0.7624
3 1.00 1.42 (0.93–2.19) 1.32 (0.85–2.04) 1.49 (0.97–2.27) 0.88 (0.55–1.40) 0.6956
Model 1: unadjusted. Model 2: age-adjusted. Model 3: adjusted for age, BMI, resting pulse and mean sitting systolic BP. ‘OH-C’ is consensus OH; ‘OH-1’ is OH
occurring within 1 minute of standing; ‘OH-2’ is OH occurring after 1 minute of standing. The given P-value is the P for trend
Table 4. Comparison of cut-offs used to define vitamin D deficiency, reference groups and time point(s) after standing at
which BP measurements were taken to assess for OH in different studies
Study Design n Age (years) Cut-off defining vitamin D
deficiency or hypovitaminosis
D (nmol/l)
Cut-off defining reference
group (nmol/l)
Time point(s) after standing
when BP was measured
Association
between vitamin D
and OH. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
McCarroll et al . [3] Case-control 76 ≥64a Continuous N/A Every 30 seconds, continuing
until 3 minutes had elapsed
Present
Annweiler et al . [1] Cross-sectional 329 80–94.3 ≤25 >25 A single measurement within
3 minutes of standing
(specific time point not specified)
Present
Soysal et al . [5] Retrospective 546 ≥65a <50 ≥50 At 1 and 3 minutes Present
Veronese et al . [6] Cross-sectional 2, 640 65–98 ≤25 >75 After 1 and 3 minutes Not present
Duval et al . [2] Prospective 51 82b ≤25 Not specified After 3 minutes Present
Veronese et al . [7] Prospective 1, 308 65–93 ≤69 in men; ≤42 in women
(cut-offs based on quartiles)
>142 in men;
>92 in women
After 1 and 3 minutes Present (not
statistically
significant in men)
Laird et al . [18] Cross-sectional 4, 209 >50a <30 ≥50 Up to 40 seconds and throughout
110 seconds poststand
Not present
Age range not specified: alower limit for inclusion; bmean age at base line
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